UspA2是跨保护性卡他莫拉菌疫苗抗原
卡他莫拉菌是成人慢阻肺急性加重和儿童中耳炎的重要病原体,UspA2因序列变异曾被放弃作为疫苗候选。本研究在AERIS研究的慢阻肺患者中检测UspA2流行率,并在动物模型中评估其免疫原性和杀菌活性。结果显示UspA2基因在所有分离株中均存在,UspA2H变异型占51%,抗UspA2抗体可交叉杀伤多种来源菌株。
要点
- UspA2基因在所有卡他莫拉菌分离株中均存在,UspA2H变异型占51%。
- UspA2免疫可清除小鼠肺部卡他莫拉菌攻击。
- 抗UspA2抗体可交叉杀伤UspA2H和UspA1表达菌株。
核心结论
- UspA2是跨反应性卡他莫拉菌抗原,具备疫苗候选特征。
研究设计与样本
- 基于AERIS研究慢阻肺患者分离株的流行率分析,以及小鼠、豚鼠、兔的免疫原性和杀菌试验。
主要发现
- UspA2基因在所有卡他莫拉菌分离株中均存在,UspA2H变异型占51%。
- UspA2免疫可清除小鼠肺部卡他莫拉菌攻击。
- 抗UspA2抗体可杀伤多种来源卡他莫拉菌株,并交叉反应UspA2H和UspA1。
关键数值与推荐
- UspA2H变异型占AERIS研究分离株的51%。
临床怎么用
- 支持UspA2作为卡他莫拉菌疫苗抗原进一步开发。
局限性
- 研究限于AERIS研究慢阻肺患者分离株和动物模型,尚未在人体中验证保护效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Moraxella catarrhalis (Mcat) is a key pathogen associated with exacerbations of chronic obstructive pulmonary disease (COPD) in adults and playing a significant role in otitis media in children. A vaccine would help to reduce the morbidity and mortality associated with these diseases. UspA2 is an Mcat surface antigen considered earlier as vaccine candidate before the interest in this molecule vanished due to sequence variability. However, the observation that some conserved domains are the target of bactericidal antibodies prompted us to reconsider UspA2 as a potential vaccine antigen. We first determined its prevalence among the COPD patients from the AERIS study, as the prevalence of UspA2 in a COPD-restricted population had yet to be documented. The gene was found in all Mcat isolates either as UspA2 or UspA2H variant. The percentage of UspA2H variant was higher than in any report so far, reaching 51%. A potential link between the role of UspA2H in biofilm formation and this high prevalence is discussed. To study further UspA2 as a vaccine antigen, recombinant UspA2 molecules were designed and used in animal models and bactericidal assays. We showed that UspA2 is immunogenic and that UspA2 immunization clears Mcat pulmonary challenge in a mouse model. In a serum bactericidal assay, anti-UspA2 antibodies generated in mice, guinea pigs or rabbits were able to kill Mcat strains of various origins, including a subset of isolates from the AERIS study, cross-reacting with UspA2H and even UspA1, a closely related Mcat surface protein. In conclusion, UspA2 is a cross-reactive Mcat antigen presenting the characteristics of a vaccine candidate.
引用
- Ysebaert C, Castado C, Mortier MC, et al. UspA2 is a cross-protective Moraxella catarrhalis vaccine antigen. Vaccine. 2021. PMID: 34446318. doi:10.1016/j.vaccine.2021.08.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。